Daniel Brungs

1.4k total citations
47 papers, 565 citations indexed

About

Daniel Brungs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Daniel Brungs has authored 47 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Daniel Brungs's work include Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (8 papers). Daniel Brungs is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (8 papers). Daniel Brungs collaborates with scholars based in Australia, United States and New Zealand. Daniel Brungs's co-authors include Morteza Aghmesheh, Therese M. Becker, Martin Carolan, Marie Ranson, Kara L. Vine, Paul de Souza, Richard J. Epstein, Joseph W. Po, Nick Pavlakis and Philip R. Clingan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daniel Brungs

41 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Brungs Australia 14 322 180 175 151 77 47 565
Giulia Orsi Italy 12 220 0.7× 171 0.9× 113 0.6× 148 1.0× 115 1.5× 34 514
Yayun Zhu China 13 473 1.5× 217 1.2× 291 1.7× 233 1.5× 130 1.7× 22 744
Andrea Ravelli Italy 10 288 0.9× 200 1.1× 106 0.6× 251 1.7× 36 0.5× 15 543
Xuelian Chen China 12 462 1.4× 218 1.2× 163 0.9× 209 1.4× 149 1.9× 36 779
Minsig Choi United States 14 360 1.1× 190 1.1× 104 0.6× 134 0.9× 82 1.1× 28 549
Giuseppe Gullo Ireland 13 368 1.1× 271 1.5× 154 0.9× 151 1.0× 59 0.8× 42 692
Fangchao Zheng China 9 425 1.3× 272 1.5× 203 1.2× 278 1.8× 130 1.7× 33 800
Gretchen Taylor United States 8 322 1.0× 145 0.8× 118 0.7× 75 0.5× 54 0.7× 11 503
Felix Meyer Germany 10 289 0.9× 341 1.9× 159 0.9× 117 0.8× 103 1.3× 20 646
Xinmin Zhao China 13 354 1.1× 263 1.5× 138 0.8× 259 1.7× 71 0.9× 47 666

Countries citing papers authored by Daniel Brungs

Since Specialization
Citations

This map shows the geographic impact of Daniel Brungs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Brungs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Brungs more than expected).

Fields of papers citing papers by Daniel Brungs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Brungs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Brungs. The network helps show where Daniel Brungs may publish in the future.

Co-authorship network of co-authors of Daniel Brungs

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Brungs. A scholar is included among the top collaborators of Daniel Brungs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Brungs. Daniel Brungs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beavis, Paul A., Junyun Lai, Gordon G. Wallace, et al.. (2025). Implantable drug delivery system improves tolerability of anti-CD40/anti-PD1 and chemotherapy in a murine model of breast cancer. European Journal of Pharmaceutical Sciences. 216. 107359–107359.
2.
Gabrail, Nashat, Miranda Gogishvili, Tamta Makharadze, et al.. (2024). A phase 2/3 study of fianlimab, cemiplimab, plus chemotherapy versus cemiplimab plus chemotherapy in first-line treatment of advanced non-small cell lung cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS8660–TPS8660. 2 indexed citations
3.
Brungs, Daniel, et al.. (2024). A Machine Learning-Driven Comparison of Ion Images Obtained by MALDI and MALDI-2 Mass Spectrometry Imaging. Journal of the American Society for Mass Spectrometry. 35(3). 466–475. 1 indexed citations
4.
Hansen, Thomas Fritz, et al.. (2024). Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer. SHILAP Revista de lepidopterología. 5(6). 1247–1260.
5.
Muñoz‐Couselo, Eva, Henri Montaudié, Miguel‐Ángel Berciano‐Guerrero, et al.. (2024). 1136P Cosibelimab in advanced cutaneous squamous cell carcinoma (CSCC): Longer-term efficacy and safety results from pivotal study. Annals of Oncology. 35. S745–S746. 1 indexed citations
6.
Geraghty, Nicholas J., Debbie Watson, Daniel Brungs, et al.. (2023). Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 24(16). 12538–12538. 4 indexed citations
7.
Brungs, Daniel, et al.. (2023). Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy. SHILAP Revista de lepidopterología. 16(1). 1415–1424. 1 indexed citations
8.
Cooper, Adam, Daniel Brungs, Joseph W. Po, et al.. (2021). Human TERT promoter mutations as a prognostic biomarker in glioma. Journal of Cancer Research and Clinical Oncology. 147(4). 1007–1017. 43 indexed citations
9.
Woodford, Rachel, Daniel Brungs, Peter Grimison, et al.. (2021). Combination chemotherapy with NAB®‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study). Asia-Pacific Journal of Clinical Oncology. 18(5). e220–e226. 8 indexed citations
10.
Po, Joseph W., Yafeng Ma, Alison W. S. Luk, et al.. (2021). Single-Cell Analysis of BRAFV600E and NRASQ61R Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells. Methods in molecular biology. 2265. 277–286.
11.
12.
Garrett, Celine, David T. Lynch, Daniel Brungs, et al.. (2020). The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients. Cancers. 12(7). 1831–1831. 33 indexed citations
13.
Geraghty, Nicholas J., Jonathan G. Williams, Daniel Brungs, et al.. (2020). Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73. Purinergic Signalling. 16(3). 389–401. 17 indexed citations
14.
Clingan, P., Daniel Brungs, Rahul Ladwa, et al.. (2020). 1084P Cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma (mCSCC): Preliminary safety and efficacy results from a phase I clinical trial. Annals of Oncology. 31. S736–S736. 6 indexed citations
15.
Clingan, Philip R., Stephen P. Ackland, Daniel Brungs, et al.. (2019). First‐in‐human phase I study of infusional and bolus schedules of Deflexifol, a novel 5‐fluorouracil and leucovorin formulation, after failure of standard treatment. Asia-Pacific Journal of Clinical Oncology. 15(3). 151–157. 2 indexed citations
16.
Brungs, Daniel, Martin Illemann, Nicholas Hirst, et al.. (2019). Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma. Pathology. 51(5). 474–480. 10 indexed citations
17.
Brungs, Daniel, David T. Lynch, Alison W. S. Luk, et al.. (2018). Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer. World Journal of Gastroenterology. 24(7). 810–818. 19 indexed citations
18.
Hayes, Aimee R., Daniel Brungs, & Nick Pavlakis. (2018). Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis. PLoS ONE. 13(1). e0191455–e0191455. 20 indexed citations
19.
Brungs, Daniel, Morteza Aghmesheh, Kara L. Vine, et al.. (2015). Gastric cancer stem cells: evidence, potential markers, and clinical implications. Journal of Gastroenterology. 51(4). 313–326. 106 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Orsi Breakdown of academic impact, for papers by Yayun Zhu Breakdown of academic impact, for papers by Andrea Ravelli Breakdown of academic impact, for papers by Xuelian Chen Breakdown of academic impact, for papers by Minsig Choi Breakdown of academic impact, for papers by Giuseppe Gullo Breakdown of academic impact, for papers by Fangchao Zheng Breakdown of academic impact, for papers by Gretchen Taylor Breakdown of academic impact, for papers by Felix Meyer Breakdown of academic impact, for papers by Xinmin Zhao
Rankless by CCL
2026